07/09/2025 6:44 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/11/2025 4:09 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025 7:39 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2025 4:06 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 3:39 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 7:37 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2025 3:28 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 7:13 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025 6:34 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 3:53 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 6:01 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
Get the Latest News and Ratings for TLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
02/21/2025 6:07 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025 6:00 AM | Kluge Andreas (Filed by) Telix Pharmaceuticals Ltd (Subject) Telix Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/14/2025 6:00 AM | Behrenbruch Christian (Filed by) Telix Pharmaceuticals Ltd (Subject) Telix Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/13/2025 7:09 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025 6:19 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 3:40 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:49 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 3:05 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 5:16 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024 6:30 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 6:00 AM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 11:15 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form EFFECT | |
11/12/2024 4:00 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form SEC STAFF ACTION | |
11/12/2024 12:33 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form CERT | |
10/29/2024 6:03 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 20FR12B/A | |
10/17/2024 4:23 PM | JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) Telix Pharmaceuticals Ltd (Subject) Telix Pharmaceuticals (Subject)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
10/17/2024 3:05 PM | Telix Pharmaceuticals Ltd (Filer) Telix Pharmaceuticals (Filer)
| Form 20FR12B | |